Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...
Goldman Sachs updated its price target on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN) shares to GBP150.67, down from GBP155.58, while reaffirming a Buy rating on the stock. The adjustment follows a ...
Citigroup raises British American Tobacco price target to 3,600 (3,200) pence - 'buy' Deutsche Bank raises Airtel Africa price target to 240 (155) pence - 'buy' Barclays raises Standard Chartered ...
CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback